All News

Nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) has been approved for the treatment of chronic fibrosing interstitial lung disease with a progressive phenotype.

Combating the opioid epidemic is a popular cause, and many organizations, government entities, and health care groups have responded.

The Warren County Health Department informed CVS Health that patients are considered to be at low risk, but is still taking precautions. 

President Donald Trump has signed a bill that will provide more than $8.3 billion to fight the coronavirus disease outbreak.

Strategies for seizing revenue opportunities outside of the PBM.

Plus, ASHP comments on the latest drug shortage.

Advil Dual Action, an ibuprofen and acetaminophen fixed-dose combination, has been approved as an OTC product for pain relief.

Boost your financial IQ with these tips on how to manage your budget and increase cash flow.

Kevin DeMass, RPh, is the owner and leader of a talented team of professionals that encounters a wide variety of patients, ailments, and medications.

A new systematic review demonstrates efficacy of direct-acting antiviral therapies and supports a recommendation for universal screening of hepatitis C virus.

The FDA announced the first drug shortage due to COVID-19, and pharmacies are having challenges keeping face masks and hand sanitizers stocked.

Pyrimethamine (Daraprim) tablets are used to treat toxoplasmosis.

British study supports exogenous boosting theory.

Rimegepant (Nurtec ODT, Biohaven),a fast-acting orally disintegrating tablet, delivers quick and sustained efficacy for patients with migraine.

In new comments to the US government, several pharmacy groups say that mergers of major companies have had significant anticompetitive effects without improving the cost and quality of health care.

A new study tested the investigational drug in combination with proton pump inhibitors for patients with gastroesophageal reflux disease.

The CDC’s 2020 National Diabetes Statistics Report outlines the current state of the disease.

The differences between antihypertension medication classes were generally small and nuanced in terms of their effect on reducing cardiovascular risks.

Separately, a pharmacy association executive urges Americans to receive the flu vaccine.

Regardless of naloxone availability, rural pharmacies can serve as an educational resource for individuals seeking access to the medication.

A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.

Bempedoic acid (Nexletol, Esperion) is a new lipid-lowering therapy option for patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease.

Several pharmacy groups said they will file a brief in the Supreme Court case, Rutledge v. the Pharmaceutical Care Management Association.

Patient access to portal self-management tools through mobile devices may help significantly improve diabetes care.

Eptinezumab-jjmr (Vyepti, Lundbeck) decreased mean monthly migraine days in adult patients in 2 phase 3 clinical trials.

FDA responds to shortages, plus other important updates.

Patients receiving methadone treatment are at most risk of overdosing during the first 4 weeks of treatment initiation and following the end of treatment.

Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.